MTOR and cervical cancer: We have shown that miR-218 inhibited the proliferation of the human cervical cancer cell line HeLa and increased chemosensitivity to cisplatin in vitro by blocking the AKT-mTOR signaling pathway, which may provide an important layer of genetic regulation in tumorigenesis and ultimately become valuable therapeutic tools.